title: Do DNA-methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up.
abstract: We investigated global methylation and histone acetylation in 50 conventional clear cell renal carcinomas (RCC), treated with radical nephrectomy, to assess their possible role as diagnostic biomarkers. The features considered in this study were patient age, tumor size and grade, percentage and intensity of 5-methylcytosine (5mc) and Acetyl-Histone (Lys 9) expression in tumor tissue. All considered parameters were correlated with patient specific survival. The mean percentage of global cellular methylation in tumoral tissue was significantly higher compared to normal peritumoral tissue (p<0.0001), while the intensity of cellular methylation was significantly higher in normal tissue than in tumoral tissue (p=0.001). The mean percentage of histone cellular acetylation in tumoral tissue was significantly lower compared to normal peritumoral tissue (p=0.0005), while the intensity of mean acetylation in neoplastic tissue was similar to the normal tissue. The percentage of global DNA methylation was significantly higher in grades 3 and 4 tumors (p=0.033). Global DNA methylation and histone acetylation in tumoral tissue did not correlate with survival. Fuhrman grade was statistically significant for prognosis (p=0.031). In conclusion, global hypermethylation and histone hypoacetylation play an important role in RCC carcinogenesis; Fuhrman grade is still considered the most important factor for patient survival; 5mc can have a role as markers of aggressiveness.
authors.affiliation: Department of Clinic and Specialistic Sciences, Marche Polytechnic University, Ancona, Italy. d.minardi@univpm.it
authors.forename: D
authors.initials: D
authors.lastname: Minardi
authors.forename: G
authors.initials: G
authors.lastname: Lucarini
authors.forename: A
authors.initials: A
authors.lastname: Filosa
authors.forename: A
authors.initials: A
authors.lastname: Zizzi
authors.forename: G
authors.initials: G
authors.lastname: Milanese
authors.forename: M
authors.initials: M
authors.lastname: Polito
authors.forename: M
authors.initials: M
authors.lastname: Polito
authors.forename: R
authors.initials: R
authors.lastname: Di Primio
authors.forename: R
authors.initials: R
authors.lastname: Montironi
authors.forename: G
authors.initials: G
authors.lastname: Muzzonigro
mesh_terms: D044503:5-Methylcytosine / Q000032:analysis; D000107:Acetylation; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002292:Carcinoma, Renal Cell / Q000235:genetics* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D019175:DNA Methylation; D005260:Female; D005500:Follow-Up Studies; D006657:Histones / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007680:Kidney Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009392:Nephrectomy
chemical_list: D006657:Histones; D044503:5-Methylcytosine